EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evaluation of steroid tests in liver diseases especially serum transaminase activity


Tokyo Jikeikai Medical Journal 99(3): 521-534
Evaluation of steroid tests in liver diseases especially serum transaminase activity
In 13 patients with chronic hepatitis, the rebound phenomenon of serum transaminase was observed after corticosteroid medication. In some, the phenomenon was prominent at the 1st stage of medication, while in others gradual increase was observed. Rapid steroid test were carried out in patients with various hepatic diseases to examine effects on serum transaminase activity. Rapid i.v. administration of steroid (hydrocortisone succinate, 25 mg) was given to healthy volunteers, patients with acute hepatitis, chronic hepatitis and liver cirrhosis, who then were all diagnosed by needle biopsy. Measurements of serum transaminase activities were carried out before and at 30, 60, 120 and 240 min after the steroid loading. Animal experiments on choline-deficient rats showed that the effects of the steroid hormone on the liver and the serum transaminase activities varied in different stages after choline-deficient diet per os. In the active stage of severe inflammation of chronic liver damage, elevation of serum transaminase activities induced by the given steroid was different from that elicited by the injury mechanism. This finding had important practical implication in the use of corticosteroids for patients with chronic liver diseases as the sign of its active stage.

(PDF 0-2 workdays service: $29.90)

Accession: 005401936



Related references

Enzyme tests in routine diagnosis. 3. Serum glutamate-oxalacetate-transaminase (SGOT) and serum lactate-dehydrogenase (SLDH) activity in liver diseases; simultaneously a contribution on differential diagnosis. Arztliche Forschung 19(12): 632-639, 1965

The Liver And Steroid Hormones. 1. The Effects Of Prednisolone On Transaminase Activity Of The Serum And Liver, And The Histology Of The Liver In Rats. Igaku to Seibutsugaku. Medicine and Biology 71: 127-133, 1965

Serum glutamic oxaloacetic transaminase activity and serum glutamic pyruvic transaminase activity in liver diseases. Indian Journal of Medical Sciences 14: 344-350, 1960

Enzymatic tests in routine diagnoses 3 The behavior of serum glutamate oxalacetate transaminase and serum lactate dehydrogenase in liver diseases Importance in differential diagnosis. 1965

Relationships between alcoholism hepatitis b surface antigen in serum liver histology and serum enzymes gamma glutamyltransferase glutamic oxalacetic transaminase glutamic pyruvic transaminase in chronic liver diseases a study of 328 patients. Italian Journal of Gastroenterology 17(1): 14-17, 1985

The transaminase activity of serum in liver diseases. Trab Pesquisas Inst Nutr Univ Brasil 6: 331-364, 1962

Activity of serum transaminase in liver diseases. Minerva Medica 48(63-64): 2592-2597, 1957

Differences in serum cholinesterase and serum glutamic oxalacetic transaminase activity in liver diseases. Wiener Zeitschrift für Innere Medizin und Ihre Grenzgebiete 41: 409-414, 1960

Significance of serum transaminase activity in liver diseases. Tohoku Igaku Zasshi 65: 57-73, 1962

Serum transaminase activity in liver and biliary tract diseases. American Journal of Gastroenterology 45(5): 348-354, 1966